Nanophotonic biosensors for point-of-care COVID-19 diagnostics and coronavirus surveillance | Zendy

Gisela RuizVega | Zendy; Maria Soler | Zendy; Laura M. Lechuga | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nanophotonic biosensors for point-of-care COVID-19 diagnostics and coronavirus surveillance

Author(s) -

Gisela RuizVega,

Maria Soler,

Laura M. Lechuga

Publication year - 2020

Publication title -

journal of physics photonics

Language(s) - English

Resource type - Journals

ISSN - 2515-7647

DOI - 10.1088/2515-7647/abd4ee

Subject(s) - covid-19 , pandemic , outbreak , coronavirus , point of care , identification (biology) , nanophotonics , point of care testing , virology , computer science , medicine , nanotechnology , biology , immunology , infectious disease (medical specialty) , disease , pathology , materials science , botany

The COVID-19 pandemic has revealed the need of novel diagnostic technologies for rapid and accurate virus detection. In the European CONVAT project, a point-of-care nanophotonic biosensor is being developed for the direct, fast and specific identification of severe acute respiratory syndrome coronavirus 2 from both human patient samples and animal reservoirs. The technology will provide a quantitative detection of the viral load and it can be implemented in decentralized settings to improve the early diagnosis and clinical management of patients as well as coronavirus environmental monitoring to prevent future outbreaks.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research